Akorn Bevétel Q/Q
Mi az Akorn Bevétel Q/Q?
A Bevétel Q/Q az Akorn, Inc. - -32.43%
Mi a Bevétel Q/Q meghatározása?
A negyedéves árbevétel-növekedés évről évre meghaladja a társaság bevételeinek növekedését az előző év azonos negyedévének százalékos arányában kifejezett teljesítményéhez képest.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Bevétel Q/Q a Health Care szektor a OTC-on cégekben a Akorn -hoz képest
Mit csinál Akorn?
Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
bevétel q/q -hoz hasonló cégek Akorn
- Lithium Consolidated nak Bevétel Q/Q -32.50% van
- Autolite (India) nak Bevétel Q/Q -32.49% van
- TasFoods nak Bevétel Q/Q -32.47% van
- Shri Dinesh Mills nak Bevétel Q/Q -32.47% van
- Everspin Technologies Inc nak Bevétel Q/Q -32.46% van
- Hi Sun Technology (China) nak Bevétel Q/Q -32.46% van
- Akorn nak Bevétel Q/Q -32.43% van
- Acrysil nak Bevétel Q/Q -32.41% van
- Puxing nak Bevétel Q/Q -32.40% van
- urban-gro nak Bevétel Q/Q -32.37% van
- urban-gro nak Bevétel Q/Q -32.37% van
- Just Dial nak Bevétel Q/Q -32.37% van
- Halo Labs nak Bevétel Q/Q -32.36% van